Pharma BP identifies what price ceilings are achievable locally and what can be done to secure high price points. At the net price level, Pharma BP identifies how to minimise the discount levels and also develops create contracting strategies to maintain price.
Understanding and gauging the acceptable price points is complex. At times, newer therapies launching in an emerging market and/or a market where there are no direct competitors present, have no price benchmarks. Identifying the optimal list and net prices through an understanding of the regional market dynamics and standards of care is key to a successful launch.
Our approach relies on in-depth qualitative and quantitative research to assess net and list prices achievable, competitor pricing, local contracting and access programs, and an analogue analysis to understand historical examples of success
